Cargando…

MMP-9 expression varies according to molecular subtypes of breast cancer

BACKGROUND: In 2014, breast cancer remains a major cause of mortality worldwide mostly due to tumor relapse and metastasis. There is currently a great interest in identifying cancer biomarkers and signalling pathways mechanistically related to breast cancer progression. Matrix metalloproteinase-9 (M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yousef, Einas M, Tahir, Muhammad R, St-Pierre, Yves, Gaboury, Louis A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150970/ https://www.ncbi.nlm.nih.gov/pubmed/25151367 http://dx.doi.org/10.1186/1471-2407-14-609

Ejemplares similares

MCM2, MCM4, and MCM6 in Breast Cancer: Clinical Utility in Diagnosis and Prognosis()()
por: Issac, Marianne Samir Makboul, et al.
Publicado: (2019)

Galectin signatuares contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets
por: Grosset, Andrée-Anne, et al.
Publicado: (2016)

Galectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer
por: Grosset, Andrée-Anne, et al.
Publicado: (2016)

Immunohistochemical Expression of MMP-9 and E-Cadherin in subtypes of Ameloblastoma
por: Farhan, Farah, et al.
Publicado: (2022)

Intrinsic subtype distribution should vary according to institutions
por: Horimoto, Yoshiya, et al.
Publicado: (2020)

CD44 Expression Profile Varies According to Maturational Subtypes and Molecular Profiles of Pediatric T-Cell Lymphoblastic Leukemia
por: Marques, Luísa Vieira Codeço, et al.
Publicado: (2018)

Bone morphogenetic protein 4 (BMP-4) and epidermal growth factor (EGF) inhibit metalloproteinase-9 (MMP-9) expression in cancer cells
por: Laulan, Nathalie Bibens, et al.
Publicado: (2015)

Response to: Intrinsic subtype distribution should vary according to institutions
por: Fischer Maranta, Angela, et al.
Publicado: (2020)

The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status
por: Glajcar, Anna, et al.
Publicado: (2019)

Towards a Better Understanding of the Relationships between Galectin-7, p53 and MMP-9 during Cancer Progression
por: St-Pierre, Yves
Publicado: (2021)

Detection of IKKε by immunohistochemistry in primary breast cancer: association with EGFR expression and absence of lymph node metastasis
por: Williams, Virginie, et al.
Publicado: (2017)

EGFR associated expression profiles vary with breast tumor subtype
por: Hoadley, Katherine A, et al.
Publicado: (2007)

Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype
por: Capasso, Immacolata, et al.
Publicado: (2014)

Expression and functions of galectin-7 in ovarian cancer
por: Labrie, Marilyne, et al.
Publicado: (2014)

Expression and Functions of Galectin-7 in Human and Murine Melanomas
por: Biron-Pain, Katherine, et al.
Publicado: (2013)

Implications of differences in expression of sarcosine metabolism-related proteins according to the molecular subtype of breast cancer
por: Yoon, Ja Kyung, et al.
Publicado: (2014)

The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis
por: Li, Hai, et al.
Publicado: (2017)

Claudin gene expression profiles and clinical value in colorectal tumors classified according to their molecular subtype
por: Cherradi, Sara, et al.
Publicado: (2019)

Pattern of distant recurrence according to the molecular subtypes in Korean women with breast cancer
por: Park, Hyung Seok, et al.
Publicado: (2012)

Ki-67 as a prognostic marker according to breast cancer molecular subtype
por: Soliman, Nahed A., et al.
Publicado: (2016)

The different prognostic impact of age according to individual molecular subtypes in breast cancer
por: Kim, Nam Hee, et al.
Publicado: (2022)

Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells
por: Grosset, Andrée-Anne, et al.
Publicado: (2014)

Expression of metalloproteinases (MMP-2 and MMP-9) in basal-cell carcinoma
por: Goździalska, Anna, et al.
Publicado: (2016)

Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer?
por: Chrabańska, Magdalena, et al.
Publicado: (2023)

Effects of varying radiation dosages on MMP1 expression, and MMP1 knockdown on the viability and migration of SW620 cells
por: Ju, Fang, et al.
Publicado: (2019)

Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in Ductal Carcinoma in Situ and Invasive Ductal Carcinoma of the Breast
por: Kim, Hee Jung, et al.
Publicado: (2006)

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes
por: Talhouet, Solene De, et al.
Publicado: (2020)

Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera
por: Rocca, G La, et al.
Publicado: (2004)

Cannabinoids in Breast Cancer: Differential Susceptibility According to Subtype
por: Almeida, Cristina Ferreira, et al.
Publicado: (2021)

Matrix Metalloproteinases MMP2 and MMP9 Are Produced in Early Stages of Kidney Morphogenesis but Only MMP9 Is Required for Renal Organogenesis In Vitro
por: Lelongt, Brigitte, et al.
Publicado: (1997)

Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas
por: Meneses-García, Abelardo, et al.
Publicado: (2008)

Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype
por: Choi, Junjeong, et al.
Publicado: (2013)

Shift work and risk of skin cancer: A systematic review and meta-analysis
por: Yousef, Einas, et al.
Publicado: (2020)

Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival
por: Joseph, Chitra, et al.
Publicado: (2020)

Investigation of colorectal cancer in accordance with consensus molecular subtype classification
por: Sawayama, Hiroshi, et al.
Publicado: (2020)

Expression and Roles of MMP-2, MMP-9, MMP-13, TIMP-1, and TIMP-2 in Allergic Nasal Mucosa
por: Mori, Sachiko, et al.
Publicado: (2012)

Prognostic Significance of ARID1A Expression Patterns Varies with Molecular Subtype in Advanced Gastric Cancer
por: Kim, Jun Yong, et al.
Publicado: (2023)

BCL2 Regulation according to Molecular Subtype of Breast Cancer by Analysis of The Cancer Genome Atlas Database
por: Hwang, Ki-Tae, et al.
Publicado: (2018)

Survival following radiotherapy in young women with localized early‐stage breast cancer according to molecular subtypes
por: Liu, Qi‐Qi, et al.
Publicado: (2019)

The therapeutic response of ER+/HER2− breast cancers differs according to the molecular Basal or Luminal subtype
por: Bertucci, François, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r5tqo7egdcr2uok4ce1vaj58sd